Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: Evidence of non-specificity

Psychiatry Research

Volumn 86, Issue 3, 1999, Pages 211-216

  Bagby, R Michael ^a   Levitan, Robert D ^a   Kennedy, Sidney H ^a   Levitt, Anthony J ^a   Joffe, Russell T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Major depression; Noradrenaline; Personality change; Serotonin

Indexed keywords

DESIPRAMINE; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AFFECT; ARTICLE; CONTROLLED STUDY; DEPRESSION; EXTRAVERSION; FEMALE; HUMAN; MALE; NEUROSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DESIPRAMINE; FEMALE; HUMANS; MALE; PAROXETINE; PERSONALITY; PERSONALITY INVENTORY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0032815348     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00041-4     Document Type: Article

References (14)

1. Akiskal H.S., Hirschfeld R.M.A., Yerevenian B.I. The relationship of personality to affective disorders. Archives of General Psychiatry. 40:1993;801-810.
2. Bagby, R.M., Costa, P.T., McCrae, R.R., Livesley, W.J., Kennedy, S.H., Levitan, R.D., Levitt, A.J., Joffe, R.T., Young, L.T., in press. Replicating the five-factor model of personality in a psychiatric sample. Personality and Individual Differences.
3. Bagby R.M., Joffe R.T., Parker J.D.A., Kalemba V., Harkness K.L. Major depression and the five-factor model of personality. Journal of Personality Disorders. 9:1995;224-234.
4. Bagby R.M., Rector N.A., Bindseil K., Dickens S.E., Levitan R.D., Kennedy S.H. Self-report ratings and informants' ratings of personalities of depressed outpatients. American Journal of Psychiatry. 155:1998;437-438.
5. Coplan J.D., Papp L.A., Pine D., Martinez J., Cooper T., Rosenblum L.A., Klein D.F., Gorman J.M. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Archives of General Psychiatry. 54:1997;643-648.
6. Costa P.T., McCrae R.R. Professional Manual for Revised NEO Personality Inventory. 1992;PAR, Odessa, FL.
7. Dubini A., Bosc M., Polin V. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. Journal of Psychopharmacology. 11(Suppl. 4):1997;S17-S23.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P), (Version 2.0). 1995;New York State Psychiatric Institute, New York.
9. Gelfin R., Gorfine M., Lerer B. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. American Journal of Psychiatry. 155:1998;290-292.
10. Hamilton M. Development of a rating scale for primary depressive illness. Journal of Clinical Psychology. 6:1967;278-296.
11. Knutson B.K., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., Terpstra J., Turner R.A., Reus V.I. Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry. 155:1998;373-379.
12. 4 and microdialysis in conscious rats. Journal of Neural Transmission. 104:1997;953-966.
13. Rosenthal R., Rosnow R.L. Essentials of Behavioral Research: Methods and Data Analysis. 1984;McGraw-Hill, New York.
14. Santor D.A., Bagby R.M., Joffe R.T. Evaluating stability and change in personality and depression. Journal of Personality and Social Psychology. 73:1997;1354-1362.